Document is current
Any future updates will be listed below
-
Authors
Bang, Injin https://orcid.org/0000-0003-0247-6056
Hattori, Takamitsu https://orcid.org/0000-0002-5502-2595
Leloup, Nadia
Corrado, Alexis https://orcid.org/0000-0002-6691-2673
Nyamaa, Atekana
Koide, Akiko https://orcid.org/0000-0003-1796-7077
Geles, Ken https://orcid.org/0000-0003-1314-0232
Buck, Elizabeth
Koide, Shohei https://orcid.org/0000-0001-5473-4358
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (P30CA01608)
- License Information
-
More Information
Article History
Received: 26 March 2024
Accepted: 13 September 2024
First Online: 22 October 2024
Competing interests
: I.B., T.H., N.L., A.K., K.G., E.B. and S.K. are listed as inventors of a patent application on the technology developed in this work. K.G. and E.B. are former and current employees of Black Diamond Therapeutics, respectively; and hold equity in Black Diamond Therapeutics. S.K. is a cofounder, receives consulting fees and hold equity in Aethon Therapeutics; is a cofounder and holds equity in Revalia Bio, and has received research funding from Aethon Therapeutics, Argenx BVBA, Black Diamond Therapeutics and Puretech Health. The other authors declare no competing interests.
